dr. snyder on ruxolitinib in patients with myelofibrosis
Published 6 years ago • 395 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
0:50
dr. snyder on how ruxolitinib and fedratinib may pave the way to transplant in myelofibrosis
-
1:19
dr. snyder discusses emerging agents in myelofibrosis
-
1:51
dr. snyder on transplant updates in myelofibrosis
-
1:35
dr. snyder discusses ongoing research in myelofibrosis
-
2:18
dr. snyder on the quest to revolutionize management of myelofibrosis
-
2:07
real-world use of ruxolitinib in patients with myelofibrosis with anemia or thrombocytopenia
-
1:25
dr. bose on the utility of ruxolitinib in myelofibrosis
-
2:22
dr. scherber discusses ruxolitinib failure in myelofibrosis
-
2:30
dr. harrison on 5-year follow-up data on ruxolitinib in patients with myelofibrosis
-
6:29
symptoms, diagnosis, and qol in patients with myelofibrosis
-
9:29
ruxolitinib’s role in treating myelofibrosis
-
1:32
dr david snyder outlines use of ruxolitinib after approval of fedratinib
-
3:20
comfort: five-year outcomes of ruxolitinib in patients with myelofibrosis
-
3:21
manifest: ruxolitinib plus pelabresib for jak-inhibitor naïve myelofibrosis
-
2:30
zilurgisertib as monotherapy or in combination with ruxolitinib in patients with mf-related anemia
-
1:27
real-world use of fedratinib in patients with mf who have failed on ruxolitinib
-
1:24
dr. mesa on current data with ruxolitinib and fedratinib in myelofibrosis
-
1:19
dr. gerds on luspatercept to treat anemia in myelofibrosis
-
0:57
dr. mesa on challenges in myelofibrosis treatment